Kromek Group PLC (AIM:KMK) said it has received an initial order for its CZT-based detector modules from a new OEM customer, which it said is an established player in the medical imaging sector in Asia.
Worth US$1.42mln in total, the contract consists of several elements and is in a key target market of single photon emission computed tomography (SPECT), it added.
Delivery and revenue recognition will be in the current financial year, the company said.
In a statement, Arnab Basu, Kromek’s chief executive, commented: “This order from a new customer in Asia underscores the requirement of CZT-based detectors due to demand globally for early diagnosis of critical illnesses leading to better patient outcomes.
“This initial order improves the group's visibility over full-year revenues, and as such the board is confident in delivering further significant growth in the year ending 30 April 2024."